Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: A contemporary single-institution experience.
12/01/2023
/
Publications
A retrospective study by the MGH group reported outcomes of 59 adult patients with medulloblastoma treated with proton CSI. Gross total resection was achieved...
Proton beam therapy for skull base chordomas: a systematic review of tumor control rates and survival rates.
12/01/2023
/
Publications
Based on the data from 16 studies involving 752 patients, this review reported outcomes of PBT for skull base chordomas. Ninety-five percent of the patients...
CNS & Leptomeningeal Disease
24/02/2023
/
Webinar
Minesh Mehta covers three indications that are very promising for proton therapy: leptomeningeal disease, low-grade glioma, and glioblastoma. Watch the talk's...
Hypofractionation in Proton Therapy: radiobiological bases and clinical applications
19/04/2023
/
Webinar
/
Hypofractionation
The use of hypofractionated schedules in proton therapy is rapidly increasing. Their application has several advantages, including the reduction of overall...
Proton Beam Therapy in the Reirradiation Setting of Brain and Base of Skull Tumour Recurrences.
05/09/2023
/
Publications
This systematic review included 12 original studies of PBT reirradiation for brain/base of skull tumor recurrences. The available clinical data showed that PBT...
Proton beam radiation therapy for vestibular schwannomas – tumor control and hearing preservation rates: a systematic review and meta-analysis.
05/09/2023
/
Publications
This meta-analysis included 8 primary studies with a total number of 587 patients with vestibular schwannomas treated with proton radiation. Overall rate of...
Cochlear-optimized treatment planning in photon and proton radiosurgery for vestibular schwannoma patients.
23/11/2023
/
Publications
This study compared photon radiosurgery plans and IMPT plans to the clinically delivered photon treatment plans of 24 vestibular schwannoma patients to...
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literature.
23/11/2023
/
Publications
This systematic review summarized results of the literature in the setting of patients treated with hypofractionated PT for benign lesions of the central...
High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis.
28/02/2024
/
Publications
This study compared the survival outcomes and toxicities of high-dose PBT of 96.6 GyRBE and CRT of 60 Gy using propensity score-matched treatment cohorts. From...
Long-term outcomes of fractionated proton beam therapy for benign or radiographic intracranial meningioma.
28/02/2024
/
Publications
This study reported outcomes of 59 (64 lesions) patients with benign intracranial meningioma treated with PBT to a median total dose of 50.4 GyRBE at 1.8 GyRBE...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.